Scott R Phelps, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 35 N Cleveland Ave, Allied Health Rehab Center, Mogadore, OH 44260 Phone: 330-628-0736 Fax: 330-628-0739 |
Christine Freudeman Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1660 Hawthorn St, Mogadore, OH 44260 Phone: 330-594-7167 |
News Archive
Cirrhosis and nonalcoholic fatty liver disease (NAFLD) are two serious liver conditions with limited pharmacological treatments. The December issues of AGA's journals - Clinical Gastroenterology and Hepatology and Gastroenterology - highlight important updates into treatments for these two debilitating diseases.
In 2012, more than 3 million people had stents inserted in their coronary arteries. These tiny mesh tubes prop open blood vessels healing from procedures like a balloon angioplasty, which widens arteries blocked by clots or plaque deposits. After about six months, most damaged arteries are healed and stay open on their own. The stent, however, is there for a lifetime.
Two New York City Health and Hospitals Corp. facilities are among the New York hospitals with the lowest rates of preventable readmissions. Hospitals face reductions in their Medicare rates starting in October, and 18 New York City hospitals will have the maximum penalty allowed under the federal health care reform law-;1% of their base Medicare reimbursement.
Cell Therapeutics, Inc. announced that Dr. Richard Van der Jagt of the Ottawa General Hospital will present at the Lymphoma and Myeloma 2009 Conference in New York an overview of CTI's pixantrone phase II and phase III clinical studies that demonstrated high rates of complete remission (CR) in relapsed/refractory aggressive and indolent non-Hodgkin's lymphoma (NHL) patients.
Merck & Co., Inc. will hold its third-quarter 2009 sales and earnings conference call with institutional investors and analysts beginning at 9:00 a.m. EDT on Thursday, Oct. 22. During the call, Richard T. Clark, chairman, president and chief executive officer, Peter N. Kellogg, executive vice president and chief financial officer, and Kenneth C. Frazier, executive vice president and president, Global Human Health, will provide an overview of Merck's financial performance for the quarter.
› Verified 1 days ago